Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients

COVID-19 convalescent plasma (CCP) has been the only specific anti-viral therapy against SARS-CoV-2 available for more than one year. Following the negative results from most randomized controlled trials on its efficacy in COVID-19 hospitalized patients and the availability of anti-spike monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchini, Massimo, Focosi, Daniele, Percivalle, Elena, Beccaria, Massimiliano, Garuti, Martina, Arar, Omar, Pecoriello, Antonietta, Spreafico, Fabio, Greco, Graziana, Bertacco, Stefano, Ghirardini, Marco, Santini, Tiziana, Schiavulli, Michele, Stefania, Muzzica, Gagliardo, Thaililja, Sammartino, Josè Camilla, Ferrari, Alessandro, Zani, Matteo, Ballotari, Alessia, Glingani, Claudia, Baldanti, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323140/
https://www.ncbi.nlm.nih.gov/pubmed/35891421
http://dx.doi.org/10.3390/v14071443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323140/
https://www.ncbi.nlm.nih.gov/pubmed/35891421
http://dx.doi.org/10.3390/v14071443

Ejemplares similares